CT Kapital OÜ
Acquisition of majority share in biotech company
Exited
- Deadline14.04.2017
- Start of investment period13.04.2017
- Start time07.04.2017 07:00
- Asset classM&A
- Investment typeOther
- Investment end date12.04.2019
- Remaining termOverdue 90+ days
- Expected rate of return15.8% p.a.
- Expected cash yield%
- No of investors502
- Goal€450 000
Executive summary
CT Kapital OÜ is a SPV established for the acquisiton of majority share in biotechnology company Cellin Technologies OÜ. The acquisition is to be financed with a 150,000 euros of owner's equity and a 450,000 euro crowdfunded loan facility.
The crowdfunded capital layer is structured as secured 2-year loan with a fixed annual interest rate of 15% . The loan pays quarterly interest and returns principal proportionally on 12th, 18th and 24th month.
Investment's IRR is 15.8%.
